Genentech - A Member of the Roche Group

  • Cultivating Collaboration: Partnering

    Learn More

    We know that great science doesn't happen in a vacuum. We look to partner with the best and the brightest in the industry to advance research and new treatments.

  • Charting the Path Forward: Portfolio Management

    Learn More

    To make a meaningful impact on a disease we make important decisions to lay out the study path and goals for a medicine. These decisions can ultimately determine whether we move forward or take a different approach.

  • Managing Risk: Safety Assessment

    Learn More

    All medicines come with risk. It's important that we understand those risks sooner rather than later. We start with clinical development and continue to evaluate even after a medicine is approved.

Discover something new with just one click.

Shuffle Most Popular Featured

FDA Approval

Medicine for people with chronic idiopathic urticaria (CIU), a form of chronic hives.

Building Towards a Sustainable Future

In an effort to increase sustainability practices on our SSF campus, we've joined the US Green Buildings Challenge.

Patient Access

Genentech is committed to ensuring price is not a barrier to access for patients. Learn about our programs.

Announcing Sunshine Track

Physicians can now use our secure online portal to review Sunshine-reportable payments before they are reported to the government.

Job Search

Search for jobs. Learn more about what is currently available. And then apply for the position at Genentech that’s right for you.

Exposing Innovation

We’re working together to shape the future of biotech. Take a look inside Genentech.

Clinical Trial Data Sharing

As part of our commitment to sharing data from our clinical trials, researchers may now request access to analyzable patient-level data. Learn more.

Our Pipeline

Our pipeline includes over 30 new molecular entities that address serious unmet medical needs.

Collaborating With Managed Care

Insights on trends, events, and therapeutic advances. Learn more at

Genentech named FORTUNE Best Company

We've been named to FORTUNE's "100 Best Companies to Work For" list for the 16th year in a row.

From Molecules to Medicines

Ann Lee-Karlon, Ph.D., SVP of Portfolio Management and operations on how teams and decision making influence drug discovery and development.

Silkscreened Stories

At Genentech, our t-shirts represent our stories - about our people, our community, and ultimately about the impact of biotechnology on medicine.

Our Medicines

Find links to info and resources on each of our medicines, including prescribing information, material data safety sheets, medication guides, and healthcare provider letters.

Pioneering Partnerships

Partnering is a relatively new phenomenon for biopharmaceutical companies, but collaboration has been part of Genentech’s DNA from the beginning.

Get to Know Us

How well do you know Genentech? Learn about who we are outside of the lab.